Literature DB >> 19008067

The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials.

Sarra L Hedden1, Robert F Woolson, Rickey E Carter, Yuko Palesch, Himanshu P Upadhyaya, Robert J Malcolm.   

Abstract

"Loss to follow-up" can be substantial in substance abuse clinical trials. When extensive losses to follow-up occur, one must cautiously analyze and interpret the findings of a research study. Aims of this project were to introduce the types of missing data mechanisms and describe several methods for analyzing data with loss to follow-up. Furthermore, a simulation study compared Type I error and power of several methods when missing data amount and mechanism varies. Methods compared were the following: Last observation carried forward (LOCF), multiple imputation (MI), modified stratified summary statistics (SSS), and mixed effects models. Results demonstrated nominal Type I error for all methods; power was high for all methods except LOCF. Mixed effect model, modified SSS, and MI are generally recommended for use; however, many methods require that the data are missing at random or missing completely at random (i.e., "ignorable"). If the missing data are presumed to be nonignorable, a sensitivity analysis is recommended.

Entities:  

Mesh:

Year:  2008        PMID: 19008067      PMCID: PMC2707817          DOI: 10.1016/j.jsat.2008.09.011

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  28 in total

Review 1.  Multivariate modeling of missing data within and across assessment waves.

Authors:  A J Figueredo; P E McKnight; K M McKnight; S Sidani
Journal:  Addiction       Date:  2000-11       Impact factor: 6.526

2.  Stratified tests, stratified slopes, and random effects models for clinical trials with missing data.

Authors:  J D Dawson; S H Han
Journal:  J Biopharm Stat       Date:  2000-11       Impact factor: 1.051

3.  Missing data: our view of the state of the art.

Authors:  Joseph L Schafer; John W Graham
Journal:  Psychol Methods       Date:  2002-06

Review 4.  Recent advances in the dissemination of contingency management techniques: clinical and research perspectives.

Authors:  Nancy M Petry; Francis Simcic
Journal:  J Subst Abuse Treat       Date:  2002-09

5.  Analyzing incomplete longitudinal clinical trial data.

Authors:  Geert Molenberghs; Herbert Thijs; Ivy Jansen; Caroline Beunckens; Michael G Kenward; Craig Mallinckrodt; Raymond J Carroll
Journal:  Biostatistics       Date:  2004-07       Impact factor: 5.899

6.  Stratified testing for treatment effects with missing data.

Authors:  W J Shih; H Quan
Journal:  Biometrics       Date:  1998-06       Impact factor: 2.571

Review 7.  From the initial clinic contact to aftercare: a brief review of effective strategies for retaining cocaine abusers in treatment.

Authors:  S T Higgins; A J Budney
Journal:  NIDA Res Monogr       Date:  1997

8.  Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up.

Authors:  S T Higgins; C J Wong; G J Badger; D E Ogden; R L Dantona
Journal:  J Consult Clin Psychol       Date:  2000-02

9.  Compliance with treatment and follow-up protocols in project MATCH: predictors and relationship to outcome.

Authors:  M E Mattson; F K Del Boca; K M Carroll; N L Cooney; C C DiClemente; D Donovan; R M Kadden; B McRee; C Rice; R G Rycharik; A Zweben
Journal:  Alcohol Clin Exp Res       Date:  1998-09       Impact factor: 3.455

10.  Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data.

Authors:  Charla Nich; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2002-10-01       Impact factor: 4.492

View more
  15 in total

1.  Compensation effects on clinical trial data collection in opioid-dependent young adults.

Authors:  Claire E Wilcox; Michael P Bogenschutz; Masato Nakazawa; George E Woody
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09-22       Impact factor: 3.829

2.  Practical tips for surgical research. Ensuring balanced groups in surgical trials.

Authors:  Forough Farrokhyar; Sohail Bajammal; Kamyar Kahnamoui; Mohit Bhandari
Journal:  Can J Surg       Date:  2010-12       Impact factor: 2.089

3.  Missing data in alcohol clinical trials: a comparison of methods.

Authors:  Kevin A Hallgren; Katie Witkiewitz
Journal:  Alcohol Clin Exp Res       Date:  2013-07-24       Impact factor: 3.455

4.  Understanding and Preventing Loss to Follow-up: Experiences From the Spinal Cord Injury Model Systems.

Authors:  Hwasoon Kim; Gary R Cutter; Brandon George; Yuying Chen
Journal:  Top Spinal Cord Inj Rehabil       Date:  2018

5.  Methods to analyze treatment effects in the presence of missing data for a continuous heavy drinking outcome measure when participants drop out from treatment in alcohol clinical trials.

Authors:  Katie Witkiewitz; Daniel E Falk; Henry R Kranzler; Raye Z Litten; Kevin A Hallgren; Stephanie S O'Malley; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2014-11       Impact factor: 3.455

6.  We-Language and Sustained Reductions in Drinking in Couple-Based Treatment for Alcohol Use Disorders.

Authors:  Kevin A Hallgren; Barbara S McCrady
Journal:  Fam Process       Date:  2015-03-21

7.  A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder.

Authors:  Aimee L McRae-Clark; Rickey E Carter; Therese K Killeen; Matthew J Carpenter; Kathleen G White; Kathleen T Brady
Journal:  Am J Addict       Date:  2010-09-21

8.  Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.

Authors:  Erik Johnsen; Rune A Kroken; Tore Wentzel-Larsen; Hugo A Jørgensen
Journal:  BMC Psychiatry       Date:  2010-03-24       Impact factor: 3.630

9.  Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial.

Authors:  Eirik Kjelby; Hugo A Jørgensen; Rune A Kroken; Else-Marie Løberg; Erik Johnsen
Journal:  BMC Psychiatry       Date:  2011-08-31       Impact factor: 3.630

10.  Predicting complete loss to follow-up after a health-education program: number of absences and face-to-face contact with a researcher.

Authors:  M J Park; Yoshihiko Yamazaki; Yuki Yonekura; Keiko Yukawa; Hirono Ishikawa; Takahiro Kiuchi; Joseph Green
Journal:  BMC Med Res Methodol       Date:  2011-10-27       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.